Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip
Status:
Unknown status
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if prolonged administration of low-dose aspirin
will prevent the progression of early-stage osteonecrosis of the femoral head and may even
reduce the extent of involvement of the femoral head by the necrotic process The design is
intended to be parallel group where a total of 114 patients will be randomized in a 1:1 ratio
to the treatment (ASA) and the control (Placebo) arms.
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre